PND52 PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1822
https://www.valueinhealthjournal.com/article/S1098-3015(19)34200-7/fulltext
Title :
PND52 PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34200-7&doi=10.1016/j.jval.2019.09.1822
First page :
Section Title :
Open access? :
No
Section Order :
11585